Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: IDXX

IDEXX Laboratories, Inc.

Healthcare | Medical - Diagnostics & Research
$557.80 +8.56 (+1.56%) as of 2026-07-14 22:05 UTC
Market Cap$44.0B
Volume786.3K
EPS (TTM)$13.08

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a $44.0B medical - diagnostics & research company trading at $557.80 (+1.6% today) — 42.6× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-07-14 22:05 UTC.

52-Week Range
Low $538.87High $594.52

What IDEXX Laboratories, Inc. does

The company operates multiple business segments including CAG (diagnostics and related services), Water, and LPD, which generate revenue from a combination of recurring services, product sales, and software offerings. Revenue is derived from both United States and international markets, with the company reporting growth across all segments during the period. Growth was driven by factors including higher volumes, increased realized prices, new business gains, and expanded product offerings such as diagnostic tests and instruments.

Summarized from IDEXX Laboratories, Inc.’s SEC filings · Read the filing ↗

Key facts
Quote
Price$557.80
Change (1D)+8.56 (+1.56%)
Market cap$44.0B
Volume786.3K shares
52-week range$538.87 – $594.52
Valuation
P/E (TTM)42.65×
EV/EBITDA29.40×
EPS (TTM)$13.08
Price/book27.41×
Return on equity65.99%
Debt/equity0.28
Returns
52-week return+3.5%
Revenue, margins & earnings
FY2021 Net income: $745MFY2021 Taxes & interest: $187MFY2021 Operating expenses: $957MFY2021 Cost of revenue: $1.33B$3.22BFY2021FY2022 Net income: $679MFY2022 Taxes & interest: $220MFY2022 Operating expenses: $1.11BFY2022 Cost of revenue: $1.36B$3.37BFY2022FY2023 Net income: $845MFY2023 Taxes & interest: $252MFY2023 Operating expenses: $1.09BFY2023 Cost of revenue: $1.47B$3.66BFY2023FY2024 Net income: $888MFY2024 Taxes & interest: $240MFY2024 Operating expenses: $1.25BFY2024 Cost of revenue: $1.52B$3.90BFY2024FY2025 Net income: $1.06BFY2025 Taxes & interest: $301MFY2025 Operating expenses: $1.30BFY2025 Cost of revenue: $1.64B$4.30BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-02
  • 2026-06-02FENNELL GEORGEExecutive Vice PresidentM639—
  • 2026-06-02FENNELL GEORGEExecutive Vice PresidentF-284$161.0K
  • 2026-06-02FENNELL GEORGEExecutive Vice PresidentM-639—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC9,945,328$6.73B-0.2%
  • BlackRock, Inc.7,212,542$4.05B-15.5%
  • VANGUARD CAPITAL MANAGEMENT LLC5,182,507$2.91BNEW
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does IDEXX Laboratories, Inc. do?

The company operates multiple business segments including CAG (diagnostics and related services), Water, and LPD, which generate revenue from a combination of recurring services, product sales, and software offerings.

What is IDXX's valuation?

IDXX trades at $557.80, 42.65× trailing earnings, 29.40× EV/EBITDA, as of 2026-07-14.

When did IDXX last file with the SEC?

IDEXX Laboratories, Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-15. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 22:05 UTC. This page is also available as JSON at /api/data?ticker=IDXX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for IDXX and 3,500+ tickers.

Create a free account — keep IDXX
For your agent
GET /api/data?ticker=IDXX

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt